Class information for:
Level 1: FOLATE RECEPTOR//FOLATE BINDING PROTEIN//FOLATE RECEPTOR ALPHA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
10553 1054 39.3 82%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
316 3       RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL 39766
1684 2             METHOTREXATE//FOLATE RECEPTOR//REDUCED FOLATE CARRIER 6769
10553 1                   FOLATE RECEPTOR//FOLATE BINDING PROTEIN//FOLATE RECEPTOR ALPHA 1054

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FOLATE RECEPTOR authKW 3450552 21% 53% 225
2 FOLATE BINDING PROTEIN authKW 822950 5% 57% 50
3 FOLATE RECEPTOR ALPHA authKW 697168 4% 63% 38
4 FARLETUZUMAB authKW 383415 1% 88% 15
5 VINTAFOLIDE authKW 260724 1% 100% 9
6 FOLATE CONJUGATE authKW 185401 1% 80% 8
7 FOLATE RECEPTOR BETA authKW 168545 1% 73% 8
8 EC145 authKW 148984 1% 86% 6
9 AUTOIMMUNE SEROL address 144837 1% 50% 10
10 FOLATE RECEPTOR TARGETING authKW 143834 1% 41% 12

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 1169 19% 0% 198
2 Pharmacology & Pharmacy 906 19% 0% 201
3 Biochemistry & Molecular Biology 601 23% 0% 245
4 Medicine, Research & Experimental 329 8% 0% 81
5 Biochemical Research Methods 262 6% 0% 65
6 Materials Science, Biomaterials 243 3% 0% 29
7 Radiology, Nuclear Medicine & Medical Imaging 237 7% 0% 74
8 Chemistry, Multidisciplinary 222 12% 0% 129
9 Chemistry, Organic 203 8% 0% 83
10 Chemistry, Medicinal 192 5% 0% 50

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AUTOIMMUNE SEROL 144837 1% 50% 10
2 RADIOPHARMACEUT SCI ETH PSI USZ 78944 1% 21% 13
3 TRANSLAT MED DIAGNOST 77249 0% 67% 4
4 ETH PSI USZ 74486 1% 43% 6
5 USZ 71905 1% 21% 12
6 MEM HERMANN CANC ONCOL 57939 0% 100% 2
7 UNIT MOL THER IES 49084 1% 17% 10
8 RADIOPHARMACEUT SCI 46541 2% 7% 22
9 MOL NEUROSURG BIOTECHNOL 32587 0% 38% 3
10 CYCLOTRON RADIOPHARMACEUT 30190 1% 15% 7

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BIOCONJUGATE CHEMISTRY 9725 4% 1% 41
2 BIOSCIENCE REPORTS 8390 2% 1% 26
3 MOLECULAR PHARMACEUTICS 5715 2% 1% 25
4 JOURNAL OF DRUG TARGETING 5357 2% 1% 17
5 ADVANCED DRUG DELIVERY REVIEWS 2101 1% 1% 14
6 NUCLEAR MEDICINE AND BIOLOGY 1747 1% 0% 15
7 JOURNAL OF NUCLEAR MEDICINE 1346 2% 0% 22
8 COMPUTER-AIDED ENGINEERING 1315 0% 5% 1
9 CANCER RESEARCH THERAPY & CONTROL 887 0% 2% 2
10 JOURNAL OF LIPOSOME RESEARCH 782 0% 1% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 FOLATE RECEPTOR 3450552 21% 53% 225 Search FOLATE+RECEPTOR Search FOLATE+RECEPTOR
2 FOLATE BINDING PROTEIN 822950 5% 57% 50 Search FOLATE+BINDING+PROTEIN Search FOLATE+BINDING+PROTEIN
3 FOLATE RECEPTOR ALPHA 697168 4% 63% 38 Search FOLATE+RECEPTOR+ALPHA Search FOLATE+RECEPTOR+ALPHA
4 FARLETUZUMAB 383415 1% 88% 15 Search FARLETUZUMAB Search FARLETUZUMAB
5 VINTAFOLIDE 260724 1% 100% 9 Search VINTAFOLIDE Search VINTAFOLIDE
6 FOLATE CONJUGATE 185401 1% 80% 8 Search FOLATE+CONJUGATE Search FOLATE+CONJUGATE
7 FOLATE RECEPTOR BETA 168545 1% 73% 8 Search FOLATE+RECEPTOR+BETA Search FOLATE+RECEPTOR+BETA
8 EC145 148984 1% 86% 6 Search EC145 Search EC145
9 FOLATE RECEPTOR TARGETING 143834 1% 41% 12 Search FOLATE+RECEPTOR+TARGETING Search FOLATE+RECEPTOR+TARGETING
10 EC20 115873 1% 67% 6 Search EC20 Search EC20

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ELNAKAT, H , RATNAM, M , (2004) DISTRIBUTION, FUNCTIONALITY AND GENE REGULATION OF FOLATE RECEPTOR ISOFORMS: IMPLICATIONS IN TARGETED THERAPY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 56. ISSUE 8. P. 1067-1084 107 78% 296
2 HILGENBRINK, AR , LOW, PS , (2005) FOLATE RECEPTOR-MEDIATED DRUG TARGETING: FROM THERAPEUTICS TO DIAGNOSTICS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 94. ISSUE 10. P. 2135-2146 85 66% 315
3 MULLER, C , (2012) FOLATE BASED RADIOPHARMACEUTICALS FOR IMAGING AND THERAPY OF CANCER AND INFLAMMATION.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 8. P. 1058 -1083 102 61% 15
4 ELNAKAT, H , RATNAM, M , (2006) ROLE OF FOLATE RECEPTOR GENES IN REPRODUCTION AND RELATED CANCERS.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 11. ISSUE . P. 506-519 107 64% 44
5 ZHAO, XB , LI, H , LEE, RJ , (2008) TARGETED DRUG DELIVERY VIA FOLATE RECEPTORS.EXPERT OPINION ON DRUG DELIVERY. VOL. 5. ISSUE 3. P. 309-319 76 70% 140
6 SIWOWSKA, K , MULLER, C , (2015) PRECLINICAL DEVELOPMENT OF SMALL-MOLECULAR-WEIGHT FOLATE-BASED RADIOCONJUGATES: A PHARMACOLOGICAL PERSPECTIVE.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 59. ISSUE 3. P. 269 -286 80 73% 0
7 SALAZAR, MD , RATNAM, M , (2007) THE FOLATE RECEPTOR: WHAT DOES IT PROMISE IN TISSUE-TARGETED THERAPEUTICS?.CANCER AND METASTASIS REVIEWS. VOL. 26. ISSUE 1. P. 141-152 80 66% 157
8 LEAMON, CP , JACKMAN, AL , (2008) EXPLOITATION OF THE FOLATE RECEPTOR IN THE MANAGEMENT OF CANCER AND INFLAMMATORY DISEASE.FOLIC ACID AND FOLATES. VOL. 79. ISSUE . P. 203-+ 80 75% 36
9 LEAMON, CP , (2008) FOLATE-TARGETED DRUG STRATEGIES FOR THE TREATMENT OF CANCER.CURRENT OPINION IN INVESTIGATIONAL DRUGS. VOL. 9. ISSUE 12. P. 1277-1286 65 87% 66
10 LOW, PS , HENNE, WA , DOORNEWEERD, DD , (2008) DISCOVERY AND DEVELOPMENT OF FOLIC-ACID-BASED RECEPTOR TARGETING FOR IMAGING AND THERAPY OF CANCER AND INFLAMMATORY DISEASES.ACCOUNTS OF CHEMICAL RESEARCH. VOL. 41. ISSUE 1. P. 120-129 46 77% 451

Classes with closest relation at Level 1


Rank Class id link
1 2341 REDUCED FOLATE CARRIER//FOLYLPOLYGLUTAMATE SYNTHETASE//ANTIFOLATE
2 8151 FOLATE//FOLIC ACID//FOOD FOLATE
3 33929 TUBULYSIN//PYRROLO 1 5 BENZOXAZEPINES//PBOX
4 9553 CANCER NANOTECHNOLOGY//SHENZHEN GENE ANTIBODY THER Y//NANOSCI NANOENGN INITIAT NUSNNI
5 16519 NAB PACLITAXEL//ALBUMIN NANOPARTICLES//ABRAXANE
6 3262 REDOX RESPONSIVE//REDUCTION SENSITIVE//PH SENSITIVE
7 28738 ELECTROCHEMICAL CYTOSENSOR//CYTOSENSOR//CHEMLIFE ENVIRONM SCI
8 19997 HYALURONIC ACID//HYALURONIC ACID CERAMIDE//GLYCYRRHETINIC ACID
9 2648 POLYMERIC MICELLES//MICELLES//POLYMER MICELLE
10 35006 SECT CELL AGING DEGENERAT//SECT ULTRASTRUCT INFECT PATHOL//EXPT MED ENVIRONM PATHOL

Go to start page